Workflow
Ventyx Biosciences, Inc. (VTYX) Discusses Positive Phase II Results of VTX3232 in Obesity and Cardiovascular Risk Factors Transcript

PresentationGood day, everyone, and welcome to today's Ventyx business update call. [Operator Instructions] Today's call is being recorded. I will stand by should you need any assistance. It is now my pleasure to turn the conference over to Mr. Alex Schwartz. Please go ahead, sir.Alex Schwartz Thank you, Sherry. Hello, everyone. Thank you for joining us today. Before we discuss the Phase II study results in greater detail, we have some preliminary items to cover. First, I'd like to know the VTX3232 results ...